Kolsås, New Zealand

Adam Heikal


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adam Heikal: Innovator in Antibacterial Compounds

Introduction

Adam Heikal is a notable inventor based in Kolsås, New Zealand. He has made significant contributions to the field of antibacterial agents through his innovative research and development. His work focuses on novel compounds that have the potential to combat bacterial infections effectively.

Latest Patents

Adam Heikal holds a patent for quinoline sulfonamide compounds and their use as antibacterial agents. This invention provides novel quinoline sulfonamide compounds of Formula I, which are designed for the treatment or prevention of bacterial infections caused by both Gram-positive and Gram-negative bacteria. The patent specifically addresses infections caused by bacteria from the Enterobactericeae, Staphylococcaceae, or Streptococcaceae families. The compounds can be formulated in pharmaceutical or veterinary compositions, particularly for use in animal husbandry. Notably, these compositions can be administered as a spray directly to the udder of bovine animals, such as cows, targeting mastitis-causing bacteria.

Career Highlights

Adam Heikal's career is marked by his dedication to research and innovation in the field of antibacterial agents. His work has led to the development of effective treatments that can significantly improve animal health and welfare. He is associated with Otago Innovation Limited, where he continues to advance his research.

Collaborations

Throughout his career, Adam has collaborated with esteemed colleagues, including Margaret Anne Brimble and Greg Murray Cook. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

In summary, Adam Heikal is a pioneering inventor whose work on quinoline sulfonamide compounds has the potential to revolutionize the treatment of bacterial infections in livestock. His contributions to veterinary medicine are invaluable, and his ongoing research promises to yield further advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…